8-K filing — Precipio, Inc. (PRPO)
Filed: 2026-08-14 AccNo: 0001104659-26-097364 Size: 227 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Read original at edgarStocks · News reference
Precipio Q2 EPS $(0.12) Down From $0.05 YoY, Sales $7.021M Up From $5.654M YoY
Precipio (NASDAQ:PRPO) reported quarterly losses of $(0.12) per share. This is a 340 percent decrease over earnings of $0.05 per share from the same period last year. The company reported $7.021 million in sales this
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Aug 14, 2026, 8:39 PM
- Checked
- Aug 14, 2026, 8:39 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
Precipio is requesting Shareholders/Brokers vote today to avoid costly adjournment and rescheduling of Annual Shareholders Meeting
Precipio Inc. (NASDAQ: PRPO) is urging shareholders to vote immediately to reach the 50% quorum requirement for its Annual Shareholders Meeting scheduled for June 15, 2026. As of the press release date, only 42% of shares had been voted. The company is seeking to avoid costly adjournment and rescheduling expenses if sufficient votes are not received by the June 14 deadline.
Read original at globenewswire-incPrecipio to Present at the Planet MicroCap Las Vegas
Precipio, Inc. (NASDAQ: PRPO), a specialty cancer diagnostics company, announced it will present at the Planet MicroCap Las Vegas 2026 conference on June 17, 2026. CEO Ilan Danieli and COO Zaki Sabet will host the presentation. The company emphasized it is profitable and focused on raising awareness and building its shareholder base rather than raising capital.
Read original at globenewswire-inc